CD8A and neoplasm: TP53 gain-of-function mutation TP53 decreases CD8+ T cell levels within TME by modulating cytokine expression, which in turn inhibits the infiltration of Tregs and M2 tumor-associated macrophages (TAMs), thereby facilitating immune escape and the progression of OSCC (12).